| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35002-1mg | |||
| Carrier-Free | NBP2-35002-100ug | |||
| Carrier-Free | NBP2-35002-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB4572-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35179-1mg | |||
| Carrier-Free | NBP2-35179-100ug | |||
| Carrier-Free | NBP2-35179-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 966-6C-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 7949-6C-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12103-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22286-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF457 | |||
| Carrier Free | AF457-SP | |||
![SDS-Page: Human CCL21/6Ckine Protein [NBP2-35002]](http://images.novusbio.com/fullsize/Human-CCL21-6Ckine-Protein-SDS-Page-NBP2-35002-img0001.jpg "SDS-Page: Human CCL21/6Ckine Protein [NBP2-35002]")
![SDS-Page: Mouse CCL21/6Ckine Protein [NBP2-35179]](http://images.novusbio.com/fullsize/Mouse-CCL21-6Ckine-Protein-SDS-Page-NBP2-35179-img0001.jpg "SDS-Page: Mouse CCL21/6Ckine Protein [NBP2-35179]")
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (MM0146-2H26) [NBP2-12103] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase K for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-MM0146-2H26-Immunohistochemistry-Paraffin-NBP2-12103-img0001.jpg "Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (MM0146-2H26) [NBP2-12103] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase K for antige retrieval before IHC is applied.")
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (RM0174-10K10) [NBP2-12104] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12104](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-RM0174-10K10-Immunohistochemistry-Paraffin-NBP2-12104-img0001.jpg "Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (RM0174-10K10) [NBP2-12104] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12104")
![Western Blot: CCL21 Overexpression Lysate (Adult Normal) [NBL1-08851] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for CCL21.](http://images.novusbio.com/fullsize/CCL21-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-08851-img0002.jpg "Western Blot: CCL21 Overexpression Lysate (Adult Normal) [NBL1-08851] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for CCL21.")
![Western Blot: CCL21/6Ckine Antibody (SR1207) [NBP3-22286] - Western blot analysis using NBP3-22286 in Human CCL21/6Ckine recombinant protein lysate.](http://images.novusbio.com/fullsize/nbp3-22286_rabbit-ccl21-6ckine-mab-sr1207-5720231754889.jpg "Western Blot: CCL21/6Ckine Antibody (SR1207) [NBP3-22286] - Western blot analysis using NBP3-22286 in Human CCL21/6Ckine recombinant protein lysate.")